[Combined FCGR2A/FCGR3A polymorphisms are prognostic factors for disease profression in metastatis colorectal cancer patients treated with cetuximab plus irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE